Literature DB >> 26941060

Transmission Clusters of Methicillin-Resistant Staphylococcus Aureus in Long-Term Care Facilities Based on Whole-Genome Sequencing.

O Colin Stine1, Shana Burrowes1, Sophia David2, J Kristie Johnson3, Mary-Claire Roghmann1.   

Abstract

OBJECTIVE To define how often methicillin-resistant Staphylococcus aureus (MRSA) is spread from resident to resident in long-term care facilities using whole-genome sequencing DESIGN Prospective cohort study SETTING A long-term care facility PARTICIPANTS Elderly residents in a long-term care facility METHODS Cultures for MRSA were obtained weekly from multiple body sites from residents with known MRSA colonization over 12-week study periods. Simultaneously, cultures to detect MRSA acquisition were obtained weekly from 2 body sites in residents without known MRSA colonization. During the first 12-week cycle on a single unit, we sequenced 8 MRSA isolates per swab for 2 body sites from each of 6 residents. During the second 12-week cycle, we sequenced 30 MRSA isolates from 13 residents with known MRSA colonization and 3 residents who had acquired MRSA colonization. RESULTS MRSA isolates from the same swab showed little genetic variation between isolates with the exception of isolates from wounds. The genetic variation of isolates between body sites on an individual was greater than that within a single body site with the exception of 1 sample, which had 2 unrelated strains among the 8 isolates. In the second cycle, 10 of 16 residents colonized with MRSA (63%) shared 1 of 3 closely related strains. Of the 3 residents with newly acquired MRSA, 2 residents harbored isolates that were members of these clusters. CONCLUSIONS Point prevalence surveys with whole-genome sequencing of MRSA isolates may detect resident-to-resident transmission more accurately than routine surveillance cultures for MRSA in long-term care facilities. Infect Control Hosp Epidemiol 2016;37:685-691.

Entities:  

Mesh:

Year:  2016        PMID: 26941060     DOI: 10.1017/ice.2016.41

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  Role of Hand Hygiene Ambassador and Implementation of Directly Observed Hand Hygiene Among Residents in Residential Care Homes for the Elderly in Hong Kong.

Authors:  Vincent C C Cheng; Hong Chen; Shuk-Ching Wong; Jonathan H K Chen; Wing-Chun Ng; Simon Y C So; Tuen-Ching Chan; Sally C Y Wong; Pak-Leung Ho; Lona Mody; Felix H W Chan; Andrew T Y Wong; Kwok-Yung Yuen
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-27       Impact factor: 3.254

3.  Longitudinal genomic surveillance of MRSA in the UK reveals transmission patterns in hospitals and the community.

Authors:  Francesc Coll; Ewan M Harrison; Michelle S Toleman; Sandra Reuter; Kathy E Raven; Beth Blane; Beverley Palmer; A Ruth M Kappeler; Nicholas M Brown; M Estée Török; Julian Parkhill; Sharon J Peacock
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

4.  Targeted gown and glove use to prevent Staphylococcus aureus acquisition in community-based nursing homes: A pilot study.

Authors:  Alison D Lydecker; Patience A Osei; Lisa Pineles; J Kristie Johnson; Jacquelyn Meisel; O Colin Stine; Laurence Magder; Ayse P Gurses; Joan Hebden; Cagla Oruc; Lona Mody; Kara Jacobs Slifka; Nimalie D Stone; Mary-Claire Roghmann
Journal:  Infect Control Hosp Epidemiol       Date:  2020-10-20       Impact factor: 3.254

5.  Association between length of residence and prevalence of MRSA colonization among residents in geriatric long-term care facilities.

Authors:  Teppei Sasahara; Ryusuke Ae; Akio Yoshimura; Koki Kosami; Kazumasa Sasaki; Yumiko Kimura; Dai Akine; Masanori Ogawa; Kenji Hamabata; Shuji Hatakeyama; Longzhu Cui
Journal:  BMC Geriatr       Date:  2020-11-18       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.